Navigation Links
John Theurer Cancer Center Announces Positive Results from Revlimid MCL-001(EMERGE) Study Leading to FDA Approval of First Oral Therapy for Refractory Mantle-Cell Lymphoma (MCL) Patients
Date:9/26/2013

with MD Anderson Cancer Center and a number of institutions around the world. This study reported the impressive activity of the first BTK (Bruton's Tyrosine Kinase) inhibitor called PCI-32765 or ibrutinib. Ibrutinib belongs to a new category of drugs targeting the BCR (B-cell receptor) pathway, which appears very critical for B-cells and lymphoma cells' survival. Ibrutinib was very well tolerated and showed activity in almost three-fourths of the patients with very durable responses. Ibrutinib is currently under priority review by the FDA as an additional therapeutic treatment option. ("Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma" NEJM August 2013).

"These two new drugs represent great hope for patients with relapsed/refractory mantle-cell lymphoma and offer a terrific opportunity moving forward for treatments in combination or after conventional chemotherapy (as maintenance or consolidation), which will definitely improve the outcome of mantle-cell lymphoma patients," said Andre Goy, M.D., M.S.

Dr. Goy previously showed the first activity of bortezomib (proteasome inhibitor) and headed the trials which led to bortezomib approval as the first new drug ever approved by the FDA for relapsed/refractory mantle cell lymphoma.

"As one of the premier Lymphoma programs in the nation, we are committed to being at the forefront of cutting-edge research and treatment," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer, Professor and Vice President of Cancer Services, John Theurer Cancer Center and President of Regional Cancer Care Associates. "MCL-001 and the approval of lenalidomide represent a breakthrough in the treatment of mantle-cell lymphoma."

About John Theurer Cancer Center at Hackensack University Medical Center
John Theurer Cancer Center at
'/>"/>

SOURCE John Theurer Cancer Center
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Revolutionary Natural Sunscreen That Can Reverse Wrinkles, Fine Lines, Sagging Skin, Laugh Lines And Potentially Reverse Cancer Cell Formation With Anti-Aging And Anti-Cancer Forming Natural Ingredients Now Available From Rejuve MD
2. New Survey Reveals U.S. Men with Advanced Prostate Cancer Worry More about Burdening Family and Friends Than Dying
3. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
4. Laser-Proton Therapy Working Group Takes Second Look at Ways to Lower Cost of Advanced Cancer Treatment
5. APPLIED INTEGRIN SCIENCES, INC. LAUNCHES CROWDFUNDING CAMPAIGN TO RAISE FUNDS FOR ITS CANCER DRUG DEVELOPMENT PROGRAM
6. In Turkey, the Use of Targeted Therapies Will Continue to Sustain the Colorectal Cancer Drug Market
7. According to Surveyed U.S. Oncologists, Zytiga is the Patient-Share Leader in First-Line Metastatic Castrate-Resistant Prostate Cancer
8. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
9. K94 Discoveries, Inc. Announces Seed Financing To Advance Targeted Drug Conjugates To Treat Pancreatic And Other Cancers
10. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
11. Study Suggests that a Single Session of Stereotactic Body Radiation Therapy (Lung Radiosurgery) is a Promising Approach for Treating Inoperable Early-Stage Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... FLORHAM PARK, N.J. , Aug. 21, 2014 ... specialty pharmacy group purchasing organization (GPO), is pleased ... (Aurora) to collaborate on a host of innovative ... will help Aurora deliver enhanced therapy management services ... Therapy Management (OTM) system. Aurora will ...
(Date:8/21/2014)... HOUSTON , Aug. 21, 2014 ... innovation in paediatric medicine by awarding the three ... Paediatric Formulation initiative (EuPFI) conference . The ... 17 – 18 in Athens, Greece ... by pharmacy students and professionals, from which three ...
(Date:8/21/2014)... 2014  SI-BONE, Inc. ( San Jose, California ... use of the iFuse Implant System, ® a ... the sacroiliac (SI) joint, announced that Priority Health ( ... Lumbar Fusion Medical Policy No. 91590-R4 providing positive coverage ... states that the fusion procedure, which employs the iFuse ...
Breaking Medicine Technology:Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
... ... ... - Spasticity Affects a Significant Number of Post-Stroke ... , , ...
... Robbins & Myers, Inc. (NYSE: RBN ) announced today that its Board of Directors approved a regular cash dividend payment of $0.0425 per share. , ... , , ... ... The dividend is payable on May 7, 2010 to shareholders of record as of ...
Cached Medicine Technology:First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 2First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 3First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 4First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 5First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 6First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 7First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 8First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity 9
(Date:8/21/2014)... 21, 2014 Lauren Collura, a mother of ... “Back to the Boardwalk” Facebook sweepstakes. Lauren, her husband, and ... four-bedroom beachfront house in Lavallette beginning this Saturday. , ... Boardwalk” sweepstakes. Last year, Horizon Blue Cross Blue Shield of ... Superstorm Sandy and decided to make it a new summer ...
(Date:8/21/2014)... 21, 2014 American Addiction Centers, a ... for individuals with drug and/or alcohol addiction, has been ... Growing Private Companies. , The company is ranked 7th ... list and 4th on the list in the “Nashville ... of 995%, American Addiction Centers (AAC) ascended to number ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Using two types ... the disease and may boost efforts to eradicate polio, ... 1,000 children in India found that giving the Salk ... been given the Sabin live-attenuated oral poliovirus vaccine (OPV) ... causes polio. The findings, reported in the Aug. ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Pleio, ... adherence, is launching a new suite of services ... offerings assist retail pharmacy by applying proven behavior ... classes, resulting in increased medication adherence, higher PDC ... As such, Pleio’s PDC-targeted offerings align retail’s desire ...
(Date:8/21/2014)... developed a way to use a laser to measure ... the laser system to a portable size, the technique ... themselves to draw blood. , "We are working hard ... to use in their daily lives," said Claire Gmachl, ... project,s senior researcher. "With this work we hope to ...
Breaking Medicine News(10 mins):Health News:American Addiction Centers Named to Inc. 500 List Recognition for Three-Year Sales Growth of 995% 2Health News:Two Polio Vaccines May Give Greater Protection Against Crippling Disease 2Health News:Pleio, Inc. Expands Adherence Offerings For Retail Pharmacy 2Health News:Laser device may end pin pricks, improve quality of life for diabetics 2Health News:Laser device may end pin pricks, improve quality of life for diabetics 3
... obese men because the telltale blood marker used to detect ... population, according to a new study led by Duke Prostate ... their bodies than normal weight men, and as a result, ... -- the gold standard for detecting prostate cancer -- can ...
... The extra blood volume produced in the obese may so ... the popular PSA test may be essentially useless for diagnosing ... in The Journal of the American Medical Association suggests. ... 13,000 prostate cancer patients at The Johns Hopkins Hospital and ...
... first reliable follow-up for patients after treatment, researchers ... Whole-body positron emission tomography (PET) scans three months ... help determine whether they,re cancer-free or require further ... difficult to determine if treatment has eliminated cervical ...
... survival of very sick children, study finds , , TUESDAY, ... team of experts at a children,s hospital can cut ... outside the intensive care unit, a new study suggests. ... improvement in mortality, so that adds to the potential ...
... offers formulas of essential prenatal ... ... Mission Pharmacal today announced,the launch of the CitraNatal(TM) family of ... of essential vitamins,and minerals for women prior to conception, throughout ...
... Kelle Ilitch, an,entrepreneur trained in Pilates, is bringing the ... boutique, Pure Element Pilates.,Ilitch,s version of the innovative barre ... weights, Pilates and dance exercises,in rapid sequence to tone ... available at any other studios in the area. ...
Cached Medicine News:Health News:Study suggests adjusting PSA scores for obese men or cancers may be missed 2Health News:Obesity-linked high blood volumes render PSA prostate cancer test less effective, study suggests 2Health News:PET Scans Can Spot Cervical Cancer's Return 2Health News:Rapid Response Teams Can Save Hospitalized Kids 2Health News:Rapid Response Teams Can Save Hospitalized Kids 3Health News:Mission Pharmacal Launches CitraNatal(TM) Prescription Prenatal Vitamin Line 2Health News:Ilitch Brings New Brand of Pilates to Metro Detroit With Opening of Studio in West Bloomfield 2Health News:Ilitch Brings New Brand of Pilates to Metro Detroit With Opening of Studio in West Bloomfield 3
For the quantitative in vitro determination of Cholesterol in serum and plasma....
For the quantitative in vitro determination of Alkaline Phosphatase in serum or plasma....
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: